Added to YB: 2025-03-04
Pitch date: 2025-02-28
PFE [bullish]
Pfizer Inc.
+3.41%
current return
Author Info
Devil Investors talk about the stock market and analyze companies that they like. Sign up for the newsletter.
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$146.5B
Pitch Price
$25.00
Price Target
35.00 (+35%)
Dividend
6.67%
EV/EBITDA
7.56
P/E
14.98
EV/Sales
3.09
Sector
Pharmaceuticals
Category
value
Pfizer Inc. - $PFE
PFE: Undervalued at $25, 5.8% yield. Challenges: patent expirations, Medicare changes, high debt. Opportunities: oncology/rare disease growth, cost-cutting, Danuglipron potential. Recent acquisitions (Seagen $43B) to offset COVID revenue drop. FCF payout high, dividend cut possible. Management sees 60B+ sales, $3 EPS. 7% growth expected. Target $35 (18x FCF).
Read full article (19 min)